Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application ("the application") for its trophoblast cell-surface antigen 2 ...
A cancer survivor who turned her own experience into a way of helping others is preparing to celebrate two years of ...
KEYTRUDA as Monotherapy Reduced Risk of Disease Progression or Death by 43% for Certain Patients With Advanced or Recurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results